STOP PRESS: British Biotech press releases earn rebuke

June 11, 1999
by DAVID MCCORMACK

Over optimistic press releases have earned pharmaceutical company
British Biotech a rebuke from the US Securities and Exchange Commission.
The UK company is the subject of a long-running SEC inquiry which is
expected to be resolved shortly.